Are you involved in drug development for neuromuscular disorders? Do you seek guidance and insights from leading experts in the field? If so, we invite you to participate in the upcoming TREAT-NMD Advisory Committee for Therapeutics (TACT) meeting, scheduled to be held in Boston from November 1st to November 3rd, 2024.
TACT is a unique assembly of internationally recognised experts in various facets of neuromuscular research and drug development. This esteemed committee provides invaluable guidance and feedback to pharmaceutical companies, academic researchers, and biotech firms engaged in the development of therapies for neuromuscular disorders.
Why Bring Your Drug Development Program to TACT?
Bringing your drug development program to TACT offers a multitude of benefits:
- Expert Evaluation: Gain insights and feedback from a diverse panel of experts with extensive experience in neuromuscular research and therapeutic development.
- Strategic Guidance: Receive strategic guidance tailored to your specific drug development program, helping to refine your approach and enhance the likelihood of success.
- Network Expansion: Connect with key opinion leaders, researchers, and stakeholders in the neuromuscular field, fostering valuable collaborations and partnerships.
- Validation: Benefit from the validation and endorsement that comes with participation in TACT, enhancing the credibility and visibility of your therapeutic endeavours which can help secure funding.
Join Us in Boston
If you are ready to take your drug development program to the next level, we encourage you to join us in Boston for the upcoming TACT meeting. Seize this opportunity to engage with top-tier experts, refine your strategy, and propel your therapeutic innovation forward.
For more information and to express your interest in participating, please reach out to the TACT coordinator, Laura Robertson. Places are limited so don’t miss out.
